SEARCH RESULTS FOR: "Tag: SAGE"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(4)
2018(5)
2017(6)
2016(5)
2015(3)
CATEGORIES
Analyst Update(3)
Buzz Stocks(8)
By the Numbers(1)
Earnings Preview(1)
Expectational Analysis(1)
General(1)
Indexes and ETFs(1)
Midday Market Check(1)
Opening View(3)
Quantitative Analysis(2)
Stock Market News(1)
Stocks On the Move(4)
Unusual Trading Activity(2)

3/20/2019 9:37 AM
The shares of SAGE Therapeutics Inc (NASDAQ:SAGE) are up 2% at $159.20, after its postpartum depression (PPD) drug, Zulresso, was approved by the Food and Drug Administration (FDA). Some experts' ne...
3/20/2019 9:21 AM
Dow Jones Industrial Average (DJI) futures are trading cautiously above fair value ahead of the final day of the Fed meeting. While next to no one is expecting an interest rate hike, investors are s...
2/15/2019 1:10 PM
Up 0.8% at $159.30, at last check, drug name SAGE Therapeutics Inc (NASDAQ:SAGE) is scheduled to report fourth-quarter earnings before the market opens on Tuesday, Feb. 19. Below, we will take a look...
1/7/2019 2:15 PM
The healthcare sector is in focus today, most notably due to Eli Lilly's (LLY) plans to buy Loxo Oncology (LOXO) for $8 billion and the J.P. Morgan Healthcare Conference. A couple other names also ma...
11/5/2018 11:56 AM
Ahead of midterm elections, U.S. stocks are trading mixed at midday. Specifically, the S&P 500 Index (SPX) is modestly higher, while the Dow Jones Industrial Average (DJI) is up triple digits, with ...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center